MRI safety in a Multidisciplinary OR environment – Janice Fairhurst, R.T. (R) MR
The MRI Safety challenges are inherent in a Multi-Modality Image Guided Operation Room. This talk will describe the potential hazards that exist in a multimodality imaging suite as it relates specifically to MRI safety and identify the key safety strategies that are used within the multidisciplinary iMRI environment to ensure safety.
Transcranial MR-guided Focused Ultrasound for Essential Tremor – Rachelle Bitton, Ph.D.
MR guided Focused ultrasound is a noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with essential tremor. This novel technology focuses multiple beams of ultrasound energy precisely and accurately on targets deep in the brain without damaging surrounding normal tissue. MR imaging is used for treatment planning and inter-procedural monitoring, providing images to pinpoint the area to treat and real time MR thermometry to monitor treatment progress. In this talk we explore the mechanism behind the technology, explore treatment protocols, show 3 year follow up results in patients, and talk about next steps for the technology.
Cardiac interventional MRI: current status and remaining technical challenges – Olivier Jaubert, Ph.D.
This talk will give a brief overview of the cardiovascular applications of interventional MRI (iMRI). We will give a description of the clinical MRI scans routinely performed at our institution in pulmonary hypertension patients. Finally we will give some future directions being investigated to resolve the remaining challenges for better translation of cardiovascular iMRI in clinical practice.
Initial experience with the clinical implementation of quantitative MRI biomarkers in a 1.5T MR-Linac – Ergys Subashi, Ph.D.
MR-guided systems, particularly the integrated MR-linac, provide a novel platform for the delivery of precision radiotherapy and may enable improvements in therapeutic response by increasing dose to the target while sparing organs at risk. The clinical implementation of these systems necessitates a review of current commissioning and quality assurance (QA) methods and, if needed, revisions to address differences with conventional MRI and radiotherapy machines. Integrated MR-linacs present with challenges that are not encountered when each component is considered separately. In this talk we will discuss our initial experience with the clinical implementation of quantitative MRI biomarkers in a 1.5T MR-Linac.